Q4 2024 |
105 |
$5.26B |
+$520M |
-$1.12B |
-$597M |
NUVL, VTRS, CNC, OSCR, RVMD
|
13F-HR |
2/14/2025, 04:00 PM |
Q3 2024 |
443 |
$6.69B |
+$890M |
-$1.14B |
-$247M |
NUVL, VTRS, CNC, MRUS, OSCR
|
13F-HR |
11/14/2024, 04:01 PM |
Q2 2024 |
433 |
$6.01B |
+$1.08B |
-$578M |
+$504M |
NUVL, VTRS, CNC, MRUS, LRMR
|
13F-HR |
8/14/2024, 04:30 PM |
Q1 2024 |
362 |
$5.72B |
+$856M |
-$1.21B |
-$353M |
NUVL, VTRS, CNC, LRMR, AHCO
|
13F-HR |
5/15/2024, 04:00 PM |
Q4 2023 |
220 |
$5.42B |
+$583M |
-$676M |
-$93M |
NUVL, VTRS, CPRX, CNC, NBIX
|
13F-HR |
2/14/2024, 04:01 PM |
Q3 2023 |
115 |
$4.53B |
+$651M |
-$732M |
-$80.6M |
NUVL, VTRS, CNC, NBIX, AHCO
|
13F-HR |
11/14/2023, 04:01 PM |
Q2 2023 |
121 |
$4.68B |
+$468M |
-$720M |
-$252M |
NUVL, VTRS, AMED, AHCO, NBIX
|
13F-HR |
8/14/2023, 05:23 PM |
Q1 2023 |
103 |
$4.48B |
+$727M |
-$422M |
+$306M |
NUVL, NBIX, CPRX, VTRS, AHCO
|
13F-HR |
5/15/2023, 04:00 PM |
Q4 2022 |
98 |
$4.83B |
+$1.03B |
-$297M |
+$734M |
NUVL, NBIX, AHCO, VTRS, CPRX
|
13F-HR |
2/14/2023, 03:11 PM |
Q3 2022 |
122 |
$4.97B |
+$950M |
-$582M |
+$368M |
NUVL, NBIX, AHCO, SILK, CMAX
|
13F-HR |
11/14/2022, 03:27 PM |
Q2 2022 |
119 |
$4.69B |
+$1.08B |
-$116M |
+$969M |
NUVL, VTRS, AHCO, NBIX, BIIB
|
13F-HR |
8/15/2022, 04:53 PM |
Q1 2022 |
111 |
$4.32B |
+$627M |
-$172M |
+$455M |
NUVL, VTRS, AHCO, NBIX, CMAX
|
13F-HR |
5/16/2022, 04:50 PM |
Q4 2021 |
123 |
$4.76B |
+$808M |
-$226M |
+$582M |
NUVL, VTRS, AHCO, CMAX, NBIX
|
13F-HR |
2/14/2022, 04:06 PM |
Q3 2021 |
132 |
$5.11B |
+$1.09B |
-$961M |
+$130M |
NUVL, VTRS, AHCO, CMAX, NBIX
|
13F-HR |
11/15/2021, 04:53 PM |
Q2 2021 |
143 |
$5.63B |
+$2.14B |
-$1.1B |
+$1.03B |
VTRS, OMIC, CMAX, AHCO, ORGO
|
13F-HR |
8/16/2021, 04:27 PM |
Q1 2021 |
133 |
$4.76B |
+$2.34B |
-$1.26B |
+$1.07B |
VTRS, EWTX, CNC, BSX, DFPH
|
13F-HR |
5/17/2021, 04:26 PM |
Q4 2020 |
129 |
$4.07B |
+$1.6B |
-$446M |
+$1.15B |
VTRS, GRAY, CNC, AFIB, LRMR
|
13F-HR |
2/16/2021, 03:23 PM |
Q3 2020 |
104 |
$4.11B |
+$1.68B |
-$324M |
+$1.36B |
MYL, IMMU, HZNP, AFIB, DFPHU
|
Restatement |
12/30/2020, 03:23 PM |
Q2 2020 |
93 |
$3.15B |
+$614M |
-$925M |
-$312M |
MYL, SDGR, DFPHU, HZNP, IMMU
|
13F-HR |
8/14/2020, 04:39 PM |
Q1 2020 |
90 |
$3.13B |
+$1.11B |
-$312M |
+$800M |
AHCO, MYL, HZNP, DFPHU, CNC
|
13F-HR |
5/15/2020, 04:13 PM |
Q4 2019 |
76 |
$3.08B |
+$638M |
-$359M |
+$279M |
AHCO, HZNP, MYL, ORTX, FIXX
|
13F-HR |
2/14/2020, 03:03 PM |
Q3 2019 |
95 |
$2.45B |
+$326M |
-$109M |
+$217M |
HZNP, MYL, ORTX, FIXX, AERI
|
13F-HR |
11/14/2019, 03:05 PM |
Q2 2019 |
97 |
$2.73B |
+$784M |
-$160M |
+$623M |
HZNP, MYL, ORTX, FIXX, AERI
|
13F-HR |
8/14/2019, 04:06 PM |
Q1 2019 |
93 |
$2.61B |
+$313M |
-$437M |
-$124M |
HZNPXXXX, FIXX, ORTX, PTLA, MYL
|
13F-HR |
5/15/2019, 04:31 PM |
Q4 2018 |
99 |
$2.5B |
+$570M |
-$104M |
+$466M |
HZNPXXXX, ORTX, FIXX, MYL, VCEL
|
13F-HR |
2/14/2019, 03:05 PM |
Q3 2018 |
103 |
$2.79B |
+$634M |
-$359M |
+$275M |
HZNPXXXX, FIXX, AERI, MYL, PTLA
|
13F-HR |
11/14/2018, 03:15 PM |
Q2 2018 |
114 |
$2.85B |
+$522M |
-$393M |
+$128M |
MNKKQ, HZNPXXXX, FIXX, MRTX, MYL
|
13F-HR |
8/14/2018, 04:30 PM |
Q1 2018 |
118 |
$2.89B |
+$866M |
-$381M |
+$485M |
MNKKQ, MYL, FIXX, HZNPXXXX, AVXS
|
13F-HR |
5/15/2018, 04:31 PM |
Q4 2017 |
98 |
$2.54B |
+$654M |
-$268M |
+$386M |
MNKKQ, MYL, HZNPXXXX, DXCM, GKOS
|
13F-HR |
2/14/2018, 03:20 PM |
Q3 2017 |
91 |
$2.22B |
+$678M |
-$247M |
+$431M |
AVXS, MCK, MYL, HZNPXXXX, GKOS
|
13F-HR |
11/13/2017, 10:38 AM |
Q2 2017 |
84 |
$1.87B |
+$297M |
-$605M |
-$308M |
AVXS, HZNPXXXX, NXTM, GILD, GILD
|
13F-HR |
8/14/2017, 04:02 PM |
Q1 2017 |
106 |
$2.59B |
+$529M |
-$572M |
-$42.8M |
AVXS, HZNPXXXX, NXTM, GILD, MYL
|
13F-HR |
5/15/2017, 04:03 PM |
Q4 2016 |
102 |
$2.43B |
+$664M |
-$149M |
+$515M |
HZNPXXXX, NXTM, AVXS, PTLA, GWPH
|
13F-HR |
2/14/2017, 04:03 PM |
Q3 2016 |
89 |
$2.14B |
+$232M |
-$576M |
-$344M |
GWPH, PTLA, HZNPXXXX, NXTM, AVXS
|
13F-HR |
11/14/2016, 03:29 PM |
Q2 2016 |
105 |
$2.51B |
+$462M |
-$174M |
+$288M |
HZNPXXXX, NXTM, GWPH, PTLA, AVXS
|
13F-HR |
8/15/2016, 10:22 AM |
Q1 2016 |
104 |
$2.33B |
+$746M |
-$42.3M |
+$704M |
HZNPXXXX, MYL, NXTM, GSKXXXX, AET
|
13F-HR |
5/16/2016, 04:05 PM |
Q4 2015 |
108 |
$2.46B |
+$424M |
-$415M |
+$9.33M |
HZNPXXXX, NXTM, DYAX, ADPTQ, GSKXXXX
|
13F-HR |
2/16/2016, 03:01 PM |
Q3 2015 |
133 |
$2.58B |
+$621M |
-$252M |
+$370M |
HZNPXXXX, NXTM, GSKXXXX, AET, FLML
|
13F-HR |
11/16/2015, 03:02 PM |
Q2 2015 |
120 |
$3B |
+$843M |
-$249M |
+$594M |
HZNPXXXX, FLML, NXTM, ARRY, DYAX
|
13F-HR |
8/14/2015, 04:18 PM |
Q1 2015 |
1 |
$1.04M |
|
|
|
|
New Holdings |
8/14/2015, 04:16 PM |
Q1 2015 |
123 |
$3.09B |
+$974M |
-$275M |
+$699M |
ASPX, HZNPXXXX, ABBV, NXTM, ARRY
|
13F-HR |
5/15/2015, 04:02 PM |
Q4 2014 |
111 |
$2.78B |
+$651M |
-$342M |
+$309M |
AUXL, ASPX, HZNPXXXX, AGN, FLML
|
13F-HR |
2/17/2015, 03:31 PM |
Q3 2014 |
130 |
$2.74B |
+$821M |
-$115M |
+$705M |
AUXL, AGN, NXTM, FLML, AAVL
|
13F-HR |
11/14/2014, 03:33 PM |
Q2 2014 |
127 |
$2.49B |
+$824M |
-$677M |
+$147M |
AUXL, ITMN, FLML, AGN, NXTM
|
13F-HR |
8/14/2014, 04:33 PM |
Q1 2014 |
124 |
$2.45B |
+$1.04B |
-$285M |
+$755M |
HUM, FLML, AUXL, LH, DRNA
|
13F-HR |
5/15/2014, 04:31 PM |
Q4 2013 |
105 |
$1.93B |
|
|
|
AUXL, QCOR, CBST, ARRY, NXTM
|
13F-HR |
2/14/2014, 03:25 PM |